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Abstracts
Recent studies have demonstrated the importance of anti-inflammation, including cellular immunity, inflammatory
mediators, reactive oxygen species, nitric oxide and several transcriptional factors, in the treatment of cerebral
ischemia. This article reviews the roles of Chinese medicinal herbs as well as their ingredients in the inflammatory
cascade induced by cerebral ischemia. Chinese medicinal herbs exert neuroprotective effects on cerebral ischemia.
The effects include inhibiting the activation of microglia, decreasing levels of adhesion molecules such as
intracellular adhesion molecule-1, attenuating expression of pro-inflammatory cytokines such as interleukin-1b and
tumor necrosis factor-a, reducing inducible nitric oxide synthase and reactive oxygen species, and regulating
transcription factors such as nuclear factor-B.
Introduction
Activation of multiple inflammatory cascades accounts
for the progressing of ischemia stroke [1]. After cerebral
ischemia, energy depletion and necrotic neuron death in
the local ischemic area start the inflammatory cascades.
The reperfusion generates reactive oxygen species (ROS)
that induce the production of cytokines and chemokines
leading peripheral leukocytes to influx into the cerebral
parenchyma and activate endogenous microglia. Then
cellular immunity, adhesion molecules, inflammatory
mediators, transcriptional factors participate in the
inflammatory process.
Anti-inflammatory treatment that inhibits specific
steps of the inflammatory cascade is a new strategy for
improving outcome after ischemia stroke [2-4]. The
anti-inflammatory agents, including a variety of nat-
ural products used in Chinese medicine, have been
shown to be able to prevent or treat ischemic stroke,
by decreasing the infarct area and neurological defi-
ciency [5]. These natural products are documented as
anti-oxidative, anti-inflammatory, anti-apoptotic and
neuro-functional regulatory agents [5]. Some active
ingredients isolated from these herbs have been identi-
fied and demonstrated to have neuroprotective actions.
Some of these compounds are andrographolide
isolated from Andrographis paniculata (Chuan-xin-
lian), oxymatrine isolated from Sophora flavescens
(Ku-shen), quercetin isolated from Sophora japonica
(Huai-hua), ferulic acid isolated from both Angelica
sinensis (Dang-gui)a n dLigusticum wallichii (Chuan-
xiong), tetramethylpyrazine isolated from Ligusticum
wallichii (Chuan-xiong), paeonol and paeoniflorin iso-
lated from Paeonia lactiflora (Bai-shao), shikonin iso-
lated from Lithospermum erythrorhizon (Zi-cao),
vanillin, 4-hydroxybenzyl alcohol and 4-hydroxybenzyl
aldehyde isolated from Gastrodia elata (Tain-ma),
puerarin from Radix Puerariae (Pueraria lobata; Ge-
gen), polydatin and emodin-8-O-b-D-glucoside isolated
from Polygonum cuspidatum (Hu-zhang), tanshinone
IIA isolated from Salviae miltiorrhiza (Dan-shen),
wogonin isolated from Scutellaria baicalensis (Huang-
qin) and apocynin isolated from Picrorhiza kurroa
(Hu-huang-lian)( F i g u r e1 ) .
This article reviews the current roles of Chinese med-
icinal herbs as well as their ingredients in the inflamma-
tory cascade induced by cerebral ischemia. Using
cerebral ischemia (OR ischemic stroke) AND herb (OR
traditional Chinese medicine) AND inflammation (OR
inflammatory OR immunity) as the keywords, we search
the English databases including PudMed, Medline, and
Cochrane library from 1980 to 2010, generating 77 arti-
cles from the initial search. * Correspondence: clhsieh@mail.cmuh.org.tw
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inflammation in cerebral ischemia
Inhibition of cellular immunity
After the onset of ischemia, cellular immunity, including
that executed by blood-derived leukocytes, microglia
and astrocytes are activated. Immune cells accumulate
in the brain tissues, leading to neuronal injury. Leuko-
cytes are the first inflammatory cells recruited into
ischemic brain tissues and potentiate injury by secreting
deleterious substances and inflammatory mediators [6].
Microglia are activated after ischemia and undergo
morphological transformation into phagocytes followed
by stimulation of toll-like receptors 4 (TLR-4) [7].
Andrographolide, a diterpenoid lactone isolated from
Andrographis paniculata that is traditionally used to
treat fever [8], reduces the activation of microglia in a
cell model of primary rat mesencephalic neuron-glia
culture [9]. Apocynin, the main active ingredient of
Picrorhiza kurroa, blocks microglia activation in a che-
mical ischemic model of cultured neuroblastoma cells
[10] (Table 1). In a rat model of permanent middle cere-
bral artery occlusion (pMCAo), andrographolide reduces
Figure 1 Chemical structures of active compounds that participates in the inflammatory cascade induced by cerebral ischemia.( 1 )4 -
hydroxybenzyl aldehyde; (2) oxymatrine; (3) ferulic acid; (4) tetramethylpyrazine; (5) paeonol; (6) 4-hydroxybenzyl alcohol; (7) vanillin; (8) puerarin;
(9) tanshinone IIA; (10) quercetin; (11) shikonin; (12) wogonin; (13) apocynin (14) paeoniflorin; (15) polydatin; (16) emodin-8-O-b-D-glucoside; (17)
andrographolide.
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of microglia; meanwhile, the inflammation process
induced by pMCAo is also suppressed. Paeonol, the
active ingredient of Paeonia lactiflora traditionally used
to treat inflammation-associated allergic rhinitis, otitis
and appendicitis, reduces the infarct area and improves
the neurological outcome in a transient middle cerebral
artery occlusion (tMCAo) rat model by inhibiting the
activation of microglia [11]. The aqueous crude extracts
of Sophora japonica, Panax notoginseng and Zizyphus
jujuba reduce the infarct area in a tMCAo model by
modulating cellular immunity. Sophora japonica,a n
anti-oxidative, anti-inflammatory, anti-platelet aggrega-
tion and cardiovascular protective agent [12], reduces
activated microglia cells labeled by ED1 [13]. Panax
notoginseng, which is beneficial to the cardiovascular
system and is used routinely to treat acute ischemia
stroke in China [14] decreases microglical density in the
peri-infarct region [15]. Zizyphus jujuba protects
ischemic damage by decreasing the gliosis of astrocytes
and microglia in the CA1 region four days after ische-
mia/reperfusion [16].
Inhibition of adhesion molecules
Adhesion molecules are crucial in the recruiting of leu-
kocytes into the brain parenchyma after ischemia. The
interaction between leukocytes and the vascular
endothelium is mediated by three main groups of cell
adhesion molecules, namely selectin (P-selectin, E-selec-
tin, and L-selectin), the immunoglobulin superfamily
including intra-cellular adhesion molecule-1 (ICAM-1),
ICAM-2 and vascular cell adhesion molecules-1
(VCAM-1), and integrins [17]. The suppression of adhe-
sion molecules is considered an important therapeutic
target [18].
Apocynin, isolated from Picrorhiza kurroa,a t t e n u a t e s
both cerebral infarct volume and neurological defect in
ischemia/reperfusion rat models [10,19-21]. The neuro-
protection by apocynin is accompanied by the suppres-
sion of ICAM in ischemic regions [20]. Treatment of
saponins extracted from Panax notoginseng and paeoni-
florin from Paeonia lactiflora inhibits expression of
ICAM-1 and MPO activity in a tMCAo rat model
[22,23]. Polydatin. i.e.3 , 4 ’,5-trihydroxystilbene-3-b-
mono-D-glucoside, one of the components isolated from
Polygonum cuspidatum, protects the brain from leuko-
cyte recruitment after ischemia injury by decreasing
adhesion molecules, including ICAM-1, VCAM-1, E-
selectin, L-selectin and integrins [24]. Polygonum cuspi-
datum is traditionally used in inflammatory diseases,
including dermatitis, abscess and hepatitis [25]. Ferulic
acid, the active compound of Angelica sinensis and
Ligusticum wallichii, exhibits similar effects. Intravenous
injection of ferulic acid (80 and 100 mg/kg) at the
beginning of tMCAo reduces cerebral infarct area and
improves neurological functions measured by neurologi-
cal deficit scores in rats by blocking ICAM-1 activity
[26].
Regulation of cytokines
Pro-inflammatory cytokines drive the inflammatory pro-
cess and aggravate inflammation. Cytokines that partici-
pate in the inflammation after cerebral ischemia include
the neurotoxic cytokines interleukin-1b (IL-1b), tumor
necrosis factor-alpha (TNF-a), neuroprotective cytokines
interleukin-6 (IL-6), interleukin-10 (IL-10) and trans-
forming growth factor-b [27]. Among these cytokines,
IL-1 and TNF-a are shown to be decreased by several
herbs (Table 2). Total saponins extracted from Panax
notoginseng reduce IL-1 activity [28]. Paeonol, apocinin
and the aqueous extract of Sophora japonica reduce IL-
1b immune-reactive cells in brain parenchyma of a
tMCAo model [13,20,29]. Andrographolide, paeoniflorin
and andrographolide inhibit both TNF-a and IL-1b
simultaneously [23,30]. Both puerarin, the principal
bioactive isoflavonoid derived from peuraria lobata and
wogonin (5,7-dihydroxy-8-methoxyflavone) isolated
from the root of Scutellaria baicalensis exert neuropro-
tection by inhibiting TNF-a. Radix puerariae is a med-
icinal plant used as antipyretic, antidiarrhetic,
diaphoretic and antiemetic agents [31]. Ethanol extract
of Radix puerariae acts as an anti-depressant in mice
undergoing cerebral ischemia/reperfusion [31]. Puerarin
reduces infarct volume in the tMCAo rat model at 50
mg/kg. The associated mechanisms include the ability to
down-regulate TNF-a [32]. Methanol extracts from the
dried roots of Scutellaria baicalensis (0.1-10 mg/kg) sig-
nificantly protect CA1 neuronal cells against transient
forebrain ischemia [33]. Wogonin induces TNF-a and
protects hippocampal neuron from death in a transient
global ischemia by four-vessel occlusion in rats [34].
Table 1 Medicinal herbs that suppress cellular responses
induced by cerebral ischemia
Targeted cells/
molecules
Herb or compound
Microglia/
microphage
andrographolide [30], paeonol [11], wogonin [34],
Sophora japonica [13], Angelica sinensis [51], Panax
Notoginseng [15], apocynin [10]
Astrocytes Zizyphus jujube [16]
Adhesion
molecules
Selectins polydatin [24]
Integrins polydatin [24]
ICAM-1 ferulic acid [26], polydatin [24], Panax Notoginseng
saponins [22], apocynin [20], paeoniflorin [23]
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After cerebral ischemia, reperfusion leads to the genera-
tion of ROS by several enzymes. Superoxide anion is
generated by cyclooxygenase (COX), xanthine dehydro-
genase, xanthine oxidase, nicotinamide adenine dinu-
cleotide phosphate (NADPH) oxidase and hypochlorous;
hydrogen peroxide (H2O2) are generated by myeloperox-
idase (MPO) and monoamine oxidase (MAO). Among
these, superoxide anion reacts with NO to generate per-
oxynitrite [35]. ROS stimulates ischemic cells to secrete
inflammatory cytokines and chemokines which cause
adhesion molecule up-regulation in the cerebral vascula-
ture and peripheral leukocyte recruitment. Once acti-
vated, inflammatory cells release a variety of cytotoxic
agents such as cytokines, matrix metalloproteinases
(MMPs), NO and ROS [36]. The MMPs are proteases
that break down extracellular proteins such as collagen,
leading to extracellular matrix remodeling in the inflam-
matory response [37]. Among the three isoforms of
NOS, namely inducible NOS (iNOS), neuronal NOS
(nNOS) and endothelial NOS (eNOS), iNOS expression
is restricted to cells involved in inflammatory responses
such as circulating leukocytes, microglia, and astrocytes
and therefore, iNOS is thought to be the most contribu-
tive NOS contributes to the ischemic injury via generat-
ing nitric oxide (NO) [36].
Herbs and their ingredients that exert neuroprotective
effects via inhibiting NO include ferulic acid, puerarin,
tetramethylpyrazine, wogonin and Panax notoginseng.
Intravenous injection of ferulic acid (80 and 100 mg/kg)
at the beginning of tMCAo abrogates the elevation of
nNOS, iNOS and p38 activation, leading to the decrease
of the number of relevant apoptotic cells in the ischemia
brain [38]. The inhibition of TNF-a by puerarin is fol-
lowed by the inhibition of iNOS expression and active
caspase-3 formation, resulting in a reduction in the
infarct volume in ischemia-reperfusion brain injury [32].
Wogonin reduces iNOS after cerebral ischemia [34].
Tetramethylpyrazine, which is isolated from Ligusticum
wallichiit, protects brain from ischemia insult [39]via
decreasing nitrotyrosine, iNOS and hydroxyl radical for-
mation [40].
In a tMCAo rat model, the luminal luciferase count in
the brain parenchyma is suppressed by Salviae miltior-
rhiza [41], which is used as a common herb to treat
acute ischemic stroke [42]. Aqueous extract of Salviae
miltiorrhiza reduces the infarct area and preserves pyra-
midal cells in tMCAo rats [43] as well as the NOS gene
expression in the cerebral cortex and caudate-putamen
in the ischemic brain [44]. The active component of Sal-
viae miltiorrhiza,t a n s h i n o n eI I A( 1 0m g / k g ,i . p . ) ,e x h i -
bits high anti-oxidative activities in a rat model of
hypoxia-ischemia encephalopathy, in which the rat is
exposed to a low oxygen environment (8%) and the
right common carotid artery is ligated [45]. The same
neuronal protective effect exists in the neonatal brain
with hypoxia-ischemia injury [45].
Aqueous extract of Gastrodia elata, which is widely
used to treat convulsive disorders, protects the brain
from ischemia in rat and in gerbil models [46,47]. The
active compound isolated from Gastrodia elata,4 -
hydroxybenzyl alcohol, may explain the neuro-protec-
tion activity. It increases the antioxidant protein includ-
ing protein disulfide isomerase and 1-Cys peroxiredoxin
(1-Cys Prx) [46]. The down-regulation of 8-hydroxy-2’-
deoxyguanosine suggests that 4-hydroxybenzyl alcohol
scavenges free radicals [48], which may be related to its
inhibition of apoptosis in a rat tMCAo model [49].
Another two compounds isolated from Gastrodia elata,
namely vanillin and 4-hydroxybenzyl aldehyde, also
show neuroprotective ability in cerebral ischemia.
Among the three compounds isolated from Gastrodia
elata, vanillin-treated animals have the greatest neuronal
Table 2 Herbs or herbal compounds that suppress the
production of inflammatory mediators and transcription
factors activated by cerebral ischemia
Targeted
molecules
Herb or compound
Inflammatory
meciators
Cytokines
IL-1b andrographolide [30], paeonol [11],Sophora japonica
[13],Panax Notoginseng saponins [28], apocynin [20],
Scutellaria baicalensis flavonoid [54]
TNF-a andrographolide [30], puerarin [32], wogonin [34]
NO
iNOS ferulic acid [38], puerarin [32], tetramethylpyrazine
[40], wogonin [34], Panax Notoginseng [15]
ROS Salviae Miltiorrhiza[41], 4-hydroxybenzyl alcohol [48],
Angelica sinensis [51], tanshinone IIA [45]
MPO ferulic acid [26], tetramethylpyrazine [52],
Anemarrhena asphodeloides [53], Panax Notoginseng
saponins [22]
SOD shikonin [57], paeonol [29], emodin-8-O-b-D-
glucoside [58], Zizyphus jujube [16], Scutellaria
baicalensis flavonoid [54]
CAT Scutellaria baicalensis isoflavoid [54], shikonin [57]
GSH shikonin [57]
OH· tetramethylpyrazine [40]
NADPH Apocinin [20]
MMP quercetin [62], Panax Notoginseng saponins [64]
Transcription
factors
NF-B andrographolide [30], oxymatrine [81], feulic acid
[26], paeoniflorin [82], wogonin [80],Panax
Notoginseng [15], apocynin [20]
P38 Oxymatrine [73], ferulic acid [38]
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sinensis (5 g/kg) simultaneously with cerebral ischemia
reduces the infarct area caused by tMCAo [50]. Oral
feeding of aqueous extracts of Angelica sinensis for
seven days (250 mg/kg/day) attenuates oxidative stress
in the brain [51].
Several Chinese medicinal herbs produce their neuro-
protective effects via suppression of MPO, including
ferulic acid, tetramethylpyrazine, Anemarrhena asphode-
loides and Panax notoginseng saponins. At the beginning
of tMCAo, intravenous injection of ferulic acid (80 and
100 mg/kg) suppresses the expression of MPO [26]. The
protective effects of tetramethylpyrazine and Panax
notoginseng saponins are associated with the reduced
ischemia/reperfusion induced MPO activity levels, indi-
cating that Panax notoginseng saponins decreases the
production of ROS and ROS-related inflammatory activ-
ity [52]. The aqueous extract of Anemarrhena asphode-
loides increases MPO activity and protects animals from
ischemia/reperfusion injury with a therapeutic time win-
dow from one hour prior to reperfusion to two hours
after reperfusion [53].
Chinese medicinal herbs that suppress ROS by
increasing the activity of antioxidative enzymes include
Scutellaria baicalensis flavonoid, shikonin, paeonol,
emodin-8-O-b-D-glucoside and Zizyphus jujube extract.
In a permanent cerebral ischemic model in rats, in
which the bilateral common carotid arteries are ligated,
oral feeding of total flavonoid (17.5-70 mg/kg) from Scu-
tellaria baicalensis increase SOD and catalase (CAT)
activity in the hippocampus and cerebral ischemia cor-
tex [54]. Paeonol as well increases superoxide dismutase
(SOD) activity after cerebral ischemia [29]. Shikonin is a
naphthoquinone pigment isolated from Lithospermum
erythrorhizon, which is traditionally used to heal wounds
and treat inflammatory dermatological diseases [55,56].
Shikonin protects the brain from ischemia in the
tMCAo mouse model by acting as an antioxidant. It up-
regulates SOD, catalase, glutathione peroxidase (GSH-
Px) activities and down-regulates glutathione (GSH)/glu-
tathione disulfide (GSSG) ratio [57]. Paeonol also exerts
anti-oxidative activity by increasing superoxide dismu-
tase (SOD) activity [29]. Emodin-8-O-b-D-glucoside,
extracted from Polygonum cuspidatum, increases the
total antioxidant capacity of cells after cerebral ischemia.
Increased SOD level and decreased MDA level reduce
infarct area and neurological defect [58]. The anti-
inflammatory effects of Zizyphus jujuba come from the
reduction of hydroxynonenal level, an indicator of lipid
peroxidation and elevation the SOD level [16]. Several
compounds are isolated from Zizyphus jujuba,s u c ha s
jujuboside [59], triterpenic acid [60] and saponins [61],
but the specific active compound responsible for the
neuroprotective effects has yet to be identified. As an
NADPH oxidase inhibitor, apocinin exerts neuroprotec-
tive effects by the blockage of ROS production in leuko-
cytes via the inhibition of NADPH oxidase, leading to
the elimination of cytokine and adhesion molecule pro-
duction [20].
Some Chinese medicinal herbs have effects on MMP-
9. Quercetin, one of the flovonoids isolated from
Sophora japonica, protects the blood-brain barrier and
elevates MMP-9 levels in the photothrombotic animal
model while the level of MMP-2 is not regulated by
quercetin [62]. Total saponins extracted from Panax
notoginseng reduces the expression of caspase-1 and cas-
pae-3, resulting in the attenuation of apoptosis [63].
Panax notoginseng saponins reduce protein levels of
MMP-9 in a mouse tMCAo model [64]. Three major
bioactive saponins have been identified to be ginseno-
side Rg1, ginsenoside Rb1 and notoginsenoside R1 [65].
Regulation of chemokines
Chemokines have a deleterious role by increasing leuko-
cyte infiltration after stroke [66]. Arachidonic acid (AA)
cascade is a downstream signal pathway of immune cells
initiated via phospholipase A2 (PLA2) and phospholipase
C (PLC) which is activated by calcium accumulation
caused by cessation of energy by ischemia [67]. PLA2
hydrolyzes glycerophospholipids to release AA, which is
metabolized through two different pathways via cycloox-
ygenase (COX) or lipoxygenase (LOX). The COX path-
way converts AA to prostaglandin H2 (PGH2) which is
then metabolized into eicosanoids, including prostacyclin
(PGI2), thromboxane A2 (TXA2), prostaglandin E2
(PGE2) and prostaglandin D2 (PGD2) [68]. These eicosa-
noids affect vasomotor regulation and increase microvas-
cular and blood-brain barrier (BBB) permeability [69,70].
AA is also converted to 5-hydroperoxyeicosateraenoic
acid (5-HPETE) by 5-LOX. 5-HPETE is then metabolized
to leukotrienes to mediate chemoattraction, brain edema
and BBB permeability [71].
Ingredients from Sophora flavescens, Panax notogin-
seng, Andrographis paniculata,a n dLigusticum wallichii
block chemokines after cerebral ischemia. Sophora fla-
vescens is used for anti-oxidation, anti-bacterial, anti-
inflammation, anti-fever, anti-arrhythmia, anti-asthma,
anti-ulcer and anti-neoplasm [72]. One of the major
alkaloids of Sophora flavescens, oxymatrine, reduces the
overexpression of phosphorylated p38, 12/15 LOX and
cytosolic PLA2 [73]. The alkaloid-free fraction extracted
by EtOAc containing two major flavonoids kurarinone
(45.5%) and sophoraflavone G (14.7%) protects the brain
from injury of pMCAo [74]. The underlying protective
mechanisms of Panax notoginseng comprise the inhibi-
tion COX-2 via blocking the nuclear factor-B( N F - B)
pathway [15]. Andrographolide reduces the infarct area
in a rat model of pMCAo by decreasing AA metabolism
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PGE2 levels induced by ischemia/reperfusion [52]
(Figure 2).
Transcription factors
During the inflammatory process, activation of a specific
transcription factor, including NF-B, mitogen-activated
protein kinase (MAPK), activator protein-1 (AP-1) and
regulation of specific gene expression are needed. Many
inflammatory genes contain NF-B binding site, such as
TNF-a, ICAM-1, iNOS and IL-6 [75].
Three MAPKs are documented during cerebral ische-
mia, namely the stress-activated protein kinases/c-Jun
N-terminal kinase (SAPK/JNK), p38 MAPK and the
extracellular signal-regulated kinases (ERKs). P38 MAPK
stabilizes and enhances the translation of mRNA encod-
ing pro-inflammatory protein [76]. The reduction of
ERKs is necessary for the recovery from ischemic stroke
[77]. Mediated through JNK cascade, AP-1 is activated
by the up-regulation of c-fos 30 minutes after the onset
of a stroke [78]. The p38 MAP kinase participates in the
mRNA expression of c-jun and c-fos after cerebral
ischemia [79].
Several Chinese medicinal herbs block inflammation
by inhibiting the NF-B pathway, including androgra-
pholide, oxymatrine, feulic acid, paeoniflorin, wogonin,
Panax notoginseng and apocynin [30,80,81]. Panax noto-
ginseng inhibits inflammatory mediators, including iNOS
and COX-2 by blocking the NF-B pathway [15]. In a
chronic cerebral ischemia rat model, in which bilateral
carotid arteries are permanently occluded, paeoniflorin
(25 mg/kg) decreases the expression of NF-Bi na s t r o -
cyte and microglia within hippocampal area [82]. The
protective effect provided by wogonin has been demon-
strated in a pMCAo model, in which wogonin reduces
the total volume of infarction and improves behavior
functions [83], associated with the reduction of NF-B
activity, but not with the regulation of mitogen-activated
protein kinases family members, p38, ERK and JNK
[80]. The inhibition of COX-2 by Panax notoginseng
may be achieved via blocking the NF-Bp a t h w a y[ 1 5 ] .
Apocynin reduces inflammation also via the inhibition
Figure 2 Molecular targets of herbal medicines for interrupting arachidonic acid metabolism.
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by oxymatrin may be related to the inhibiting of the
NF-B and p38 activation [73]. The decreases of ICAM-
1 and MPO by ferulic acid also considered a result of
the suppression of NF-B [26] and the inhibition of p38
may lead to the decrease of relevant apoptosis [38].
Clinical trials
Most clinical trials of Chinese medicine on ischemic
stroke test the efficacy of multi-herb formulae. For
example, Danqi Piantang Jiaonang containing Salviae
miltiorrhiza, Ligusticum wallichii, Angelica sinensis
improved neurological recovery in patients after a stroke
[84]. A multi-center randomized controlled trial (RCT)
suggested Danqi Piantang Jiaonang to increase the
scores evaluated by diagnostic therapeutic effects of
Apoplexy scoring system in post-stroke rehabilitation
and in the recovery of patients with posterior circulation
infarction and severe ischemic stroke [85,86]. Two other
clinical studies for two Chinese herbal formulae, namely
Dengzhan Shengmai capsule and Huatuo Zaizao Wan
are currently in progress. On the other hand, few single
herbs have been tested in clinical trials. In a multi-cen-
ter, double-blinded, randomized controlled clinical trial
of 140 patients suffering subacute ischemic stroke,
Panax notoginseng ameliorated neurological deficit and
activities of daily living [87]. Chen et al reported that by
reviewing several papers including 660 patients in RCTs,
Panax notoginseng was safe and beneficial [14]. Salviae
miltiorrhiza has been studied in clinical trials; however,
the results were inconclusive. A systematic review of 33
Salviae miltiorrhiza trials for acute ischemic stroke did
not support the efficacy of Salviae miltiorrhiza in dis-
ability improvement after acute ischemic stroke [42].
These clinical trials share similar problems, e.g. lack of
placebo-controlled trial and small sample size [14,42].
Conclusions
Many Chinese medicinal herbs that act on the inflam-
mation process were used to treat ischemia stroke.
These herbs suppress inflammatory cascades in cellular
immunity, adhesion molecules, cytokines, arachidonic
acid, metabolites, NO, ROS, and transcriptional factors.
In the future, more clinical trials should be down to
Chinese herbs that have been demonstrated effective in
animal studies but not been proven in human.
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